AlphAIAlphAI — Financial news for AI agents
rttnews.comOCT 302 min read$CL

Colgate-Palmolive Q3 Results Rise, Lifts FY26 Base Business EPS View; Stock Gains

Colgate-Palmolive reported Q3 earnings of $0.94 per share, up 3% YoY. The company raised its FY26 Base Business EPS growth guidance to 5-7% and adjusted gross profit margin expectations. Shares gained 5% in pre-market trading. FY25 sales were $20.382B. Q3 net sales rose 4.6% to $5.369B, with organic sales up 3.6%.

Original reporting
rttnews.com
Published Oct 30, 2026, 12:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 12:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$CL
Bullish
high confidence
Mentioned
$CL
Relevance
8/10
AlphAI data visualization · based on rttnews.com
Decision brief

The 30-second read

$CLBullishHigh
01

Why it matters

The earnings beat and guidance lift provide a fresh catalyst for price action, especially given the pre‑market rally.

02

Market read

The earnings surprise and guidance upgrade are likely to drive short‑term buying pressure and may influence sector sentiment.

03

What to watch

Potential headwinds from macro‑uncertainty and weaker North America sales could temper long‑term upside.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Colgate-Palmolive posted Q3 results with modest sales growth and raised FY26 guidance for its Base Business segment.

Company-level read

Ticker impact

$CLBullishHigh confidence
Context

Colgate-Palmolive reported Q3 earnings and raised FY26 Base Business EPS and gross margin guidance, causing a ~5% pre‑market stock gain.

Expected impact

upward pressure as the market prices in higher EPS and margin outlook

Evidence & confidence

The company beat prior quarter results and lifted guidance, a material new fact for a large‑cap consumer staple, prompting immediate buying interest.

Market effects

Sector

Higher consumer‑staples earnings may lift peers in the sector, reinforcing bullish sentiment for discretionary and household goods.

Regional

U.S. consumer‑goods market gains as a blue‑chip beats expectations.

Global

Limited to U.S. markets; modest ripple to global consumer‑goods indices.

Counterpoint

What could challenge this read

If margin improvements prove unsustainable, the stock could face a pull‑back after the initial rally.

Key entities

  • Company
    Colgate-Palmolive Co.

    Consumer products maker reporting Q3 results and FY26 guidance raise.

Read at source← All news

StoryColgate-Palmolive posts Q3 2026 beat and raises full‑year Base Business EPS outlook

Also covered by

4 outlets

Related articles

NOV 2
$CLMed

BofA raises Colgate-Palmolive stock price target to $105 on earnings

BofA Securities raised its price target for Colgate-Palmolive (NYSE:CL) to $105 from $100, citing strong earnings and updated fiscal 2026 guidance. The company reported Q3 earnings of $0.97 per share, exceeding estimates, with revenue of $5.37 billion. Colgate updated its outlook, expecting 4% to 5% net sales growth and 5% to 7% earnings growth. Analysts from UBS and Wells Fargo also raised their price targets.

investing.com2 min
NOV 2
$CLMedAI 8/10

Wells Fargo raises Colgate-Palmolive stock price target on solid Q3

Wells Fargo raised its price target for Colgate-Palmolive (NYSE:CL) to $95 from $90, citing solid Q3 2026 results. The firm noted strong performance despite macroeconomic challenges and inflation. CL's P/E ratio is 37.77, and it is considered overvalued. Q3 earnings beat expectations with $0.97 EPS on $5.37B revenue. UBS also raised its target to $112, highlighting strong margins.

investing.com2 min
NOV 2
$CLMed

UBS raises Colgate-Palmolive stock price target on margin strength

UBS raised its price target for Colgate-Palmolive (CL) to $112 from $106, citing strong Q3 earnings, revenue, and margins. The company beat EPS estimates and raised 2026 guidance. UBS expects continued sales growth despite inflation and FX headwinds, though the stock is slightly overvalued. CL reported Q3 adjusted EPS of $0.97 on revenue of $5.37B, exceeding expectations.

investing.com1 min
NOV 1
$CLMed

Colgate-Palmolive Co (CL) (Q3 2026) Earnings Call Highlights: Broad-Based Organic

Colgate-Palmolive (CL) reported Q3 2026 earnings, highlighting 6.5% organic growth in Hills pet food and strong volume leverage. CEO Noel Wallace attributed margin gains to pricing, innovation, and ad spend efficiency. CFO Stan Sutula noted material cost headwinds offset by productivity and pricing. Latin America grew 6%, with Brazil up double-digits. US toothpaste showed slight improvement, with more pricing expected.

finance.yahoo.com2 min
OCT 30
$CLHighAI 8/10

Colgate-Palmolive Company Q3 2026 Earnings Call Summary

Colgate-Palmolive reported Q3 2026 earnings, highlighting organic growth in emerging markets and Europe. Gross margin expansion was driven by pricing strategy and manufacturing leverage. The company is transitioning its U.S. go-to-market structure and integrating AI for revenue growth. Hill's Pet Nutrition saw strong performance in high-growth segments.

finance.yahoo.com3 min
OCT 30
$CLHighAI 8/10

Colgate-Palmolive Q3 Earnings Call Highlights

Colgate-Palmolive (CL) reported Q3 earnings, noting elevated commodity and logistics costs. Hill's Pet Nutrition saw 6.5% organic sales growth, driven by cat food and wet food. U.S. toothpaste market share shows early improvement. Latin America grew 6%, with Brazil up double digits. Asia-Pacific rose 5%, led by India. Full-year cost inflation is estimated at $300M. The company plans to provide 2027 guidance in Q1 next year.

finance.yahoo.com3 min